Business Broker vs. Healthcare M&A Advisor: What Owners Should Know Before Choosing
- 6 hours ago
- 7 min read
By Cory Mertz, M&AMI | Managing Partner, Mertz Taggart
At a Glance Healthcare business owners considering a sale or recapitalization will encounter business brokers, M&A advisory firms, and investment banks. Each serves a purpose, but they operate very differently. Brokers typically handle smaller transactions and market companies broadly. M&A advisory firms run structured, competitive processes targeting strategic and financial buyers. Understanding which path fits your situation can make a meaningful difference in your outcome. |
Not every transaction requires the same type of advisor.
That’s the point I think healthcare business owners need to understand before they start comparing firms, fees, or processes. A business broker, an M&A advisory firm, and an investment bank may all help owners sell or recapitalize a company, but they’re not built for the same situations.
This isn’t about one being good and the other being bad. Brokers serve an important role in the lower end of the market. For the right type of business, a broker-led process can make sense.
But when you’re talking about a sizable healthcare services business, especially one that could attract strategic acquirers or private equity-backed buyers, the process needs to be different.
The advisor you choose should match the business you built, the buyer universe you need to reach, and the outcome you’re trying to achieve. You only get to do this once.
Brokers, M&A advisors, and investment banks are not the same thing
The lines can get blurry because people often use these terms interchangeably. But there are important differences.
A business broker typically works on smaller transactions, often owner-operated businesses generally up to $2–3 million in enterprise value, though the range varies. The process is usually listing-driven. The broker prepares basic materials, markets the opportunity broadly, sometimes through listing websites like BizBuySell, and waits for interested buyers to come forward. That model can work well when the buyer universe includes individuals, searchers, or someone looking to buy themselves a career. They call them listings. For us, they’re engagements. It’s a different mindset.
An M&A advisory firm typically works with larger, more complex companies, usually $5 million and above in enterprise value, sometimes lower depending on the situation. Instead of listing the business publicly, the advisor identifies a curated group of strategic and financial buyers, prepares a comprehensive data book and offering memorandum, manages confidentiality, runs buyers through a coordinated process, and negotiates from competitive leverage.
An investment bank is a more specific designation. Investment banks are registered with the SEC as broker-dealers. They may be involved in debt raises, capital raises, growth equity, Series A, B, or C financing, and other work that requires that registration. M&A advisory firms are not licensed for that kind of work. What they can do — and what Mertz Taggart does — is represent owners in majority-stake M&A transactions, including private equity recapitalizations. In everyday conversation, people sometimes use “investment bank” to describe any firm running a larger M&A process. But technically, not every M&A advisory firm is an investment bank, and that’s an important distinction.
For most healthcare business owners, the more practical question isn’t the label. It’s this: what type of process does my business require?
A listing is not the same as a competitive process
One of the biggest differences between a broker and an M&A advisor is how the business goes to market.
For brokers, the company is often treated like a listing, with an asking price. The business may be posted on a website or marketed to a broad audience. Offers come in as they come in. There is no established timeline. The seller reviews them one at a time. If one looks reasonable, the parties may move to a letter of intent or even a purchase agreement quickly.
That can be appropriate for some businesses.
But a larger healthcare services company is different. You’re not trying to find just any buyer. You’re trying to identify the right buyer, at the right time, under the right conditions, with the right terms.
A competitive M&A process brings qualified buyers to the table on the same timeline, with the same information, and with a clear understanding that they’re competing. That structure changes buyer behavior. It creates urgency. It gives you a better view of the market. And it gives your advisor a stronger position when negotiating price and terms.
Not every transaction is an exit
Here’s something else worth understanding. When people hear “selling a business,” they usually picture the owner walking away with a check. That happens, but it’s not the only type of transaction.
We draw a distinction between an exit and a transaction. An exit means the owner sells everything and walks away. A transaction can also mean selling a majority stake to a financial partner while usually staying on to run the business — same owner, different capital structure.
That second scenario is a big one. A lot of owners have grown their companies to a point where they want to take some chips off the table, bring on a partner with resources, and take the business to the next level. That’s not an exit, that’s a recapitalization, that requires a process built for that kind of buyer. This is typically a financial sponsor (private equity firm, family office, independent sponsor), not an individual looking to buy a business.
Why does healthcare M&A require specialized experience?
Healthcare transactions are not generic business sales. A home health agency, hospice, home care company, behavioral health provider, or infusion business comes with a specific set of factors buyers will evaluate closely: reimbursement risk, referral diversity, clinical documentation, compliance history, quality metrics, payer mix, transition risk, and management depth. Most owners understand their business operationally but may not know how buyers evaluate those same factors in a transaction context.
That's where healthcare-specific experience matters. A good advisor isn't just finding a buyer. The advisor should be helping you understand what buyers will focus on before the business is exposed to the market, which issues are likely to surface during diligence, which buyers are credible, which are known for retrading after an LOI is signed, and which are most likely to value the specific strengths of your company. That kind of judgment is different from general M&A experience, and different again from having built and sold a healthcare business yourself, which is the perspective Mertz Taggart's principals bring to every engagement.
The stakes around process and buyer selection are real. The wrong buyer can consume months without closing. The wrong process creates unnecessary market exposure, and in healthcare, where agencies operate in tight-knit communities, confidentiality is not a courtesy. It's a strategic requirement. A company surfacing on a listing website creates a fundamentally different dynamic than one introduced confidentially to a pre-qualified buyer list.
The right advisor helps reduce surprises
Owners often focus on price, and they should. For many founders, the business represents most of their net worth. Getting the best possible outcome matters, but price is only one part of the transaction.
A strong M&A process is also designed to reduce late-stage surprises. That means setting expectations early, preparing buyers properly, managing information flow, and keeping pressure on the process from first outreach through close.
Some of the most difficult issues in a transaction don’t show up in the first offer. They show up later, during diligence, legal negotiations, financing, regulatory review, or final closing mechanics.
That’s when advisor involvement matters most. In a broker-led process, much of the heavy lifting happens before the LOI is signed. In a larger M&A process, the LOI is not the finish line. It’s the beginning of a more demanding phase. Your advisor should still be there, still pushing, still protecting your interests, still managing the buyer toward close.
Questions to ask before choosing an advisor
Before hiring anyone, ask direct questions about the process. The answers will tell you a lot about how they work and whether they’re the right fit for your situation.
Who is the likely buyer for my business?
Will you market the company broadly, or will you build a targeted buyer list?
Will my business be publicly listed anywhere?
What materials will you prepare before going to market?
How do you protect confidentiality?
How many buyers will be contacted, and how will they be screened?
Do you have relationships with strategic and financial buyers in my sector?
What happens after an LOI is signed?
Who will be involved during diligence and negotiation?
How do you create competition instead of simply fielding interest?
Key Takeaways
|
Ready to learn more?
If you’re thinking about what’s next for your healthcare business, whether that’s a full exit or bringing on a financial partner, we’re happy to have a confidential conversation. No pressure. No obligation. Just a straightforward discussion about where you are, what your business might be worth, and what your options look like.
Most owners wait longer than they should to start these conversations, not because they aren’t thinking about an exit, but because they aren’t sure if the timing is right or whether the business is ready. Those are questions worth working through with an advisor who knows the market, before you’re in the middle of a process.
Mertz Taggart has been advising healthcare services owners for nearly two decades. We know this space because we’ve lived in it. Reach out to start a conversation.
Legacy Preserved. Value Enhanced.
Comments